Latest PERCEPTIVE ADVISORS LLC Stock Portfolio
$5.76Billion– No. of Holdings #105
PERCEPTIVE ADVISORS LLC Performance:
2024 Q1: 9.95%YTD: 9.95%2023: 28.68%
Performance for 2024 Q1 is 9.95%, and YTD is 9.95%, and 2023 is 28.68%.
About PERCEPTIVE ADVISORS LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, PERCEPTIVE ADVISORS LLC reported an equity portfolio of $5.8 Billions as of 31 Mar, 2024.
The top stock holdings of PERCEPTIVE ADVISORS LLC are CERE, FOLD, IOVA. The fund has invested 7.9% of it's portfolio in CEREVEL THERAPEUTICS HLDNG I and 5.7% of portfolio in AMICUS THERAPEUTICS INC.
The fund managers got completely rid off LIANBIO (LIAN), CYMABAY THERAPEUTICS INC (CBAY) and RAYZEBIO INC stocks. They significantly reduced their stock positions in AMYLYX PHARMACEUTICALS INC (AMLX), ABBVIE INC (ABBV) and RAPT THERAPEUTICS INC (RAPT). PERCEPTIVE ADVISORS LLC opened new stock positions in VIKING THERAPEUTICS INC (VKTX), CG ONCOLOGY INC and PRAXIS PRECISION MEDICINES I (PRAX). The fund showed a lot of confidence in some stocks as they added substantially to CAREMAX INC (CMAX), INTRA-CELLULAR THERAPIES INC (ITCI) and MORPHIC HLDG INC (MORF).
The top stock holdings of PERCEPTIVE ADVISORS LLC are CERE, FOLD, IOVA. The fund has invested 7.9% of it's portfolio in CEREVEL THERAPEUTICS HLDNG I and 5.7% of portfolio in AMICUS THERAPEUTICS INC.
The fund managers got completely rid off LIANBIO (LIAN), CYMABAY THERAPEUTICS INC (CBAY) and RAYZEBIO INC stocks. They significantly reduced their stock positions in AMYLYX PHARMACEUTICALS INC (AMLX), ABBVIE INC (ABBV) and RAPT THERAPEUTICS INC (RAPT). PERCEPTIVE ADVISORS LLC opened new stock positions in VIKING THERAPEUTICS INC (VKTX), CG ONCOLOGY INC and PRAXIS PRECISION MEDICINES I (PRAX). The fund showed a lot of confidence in some stocks as they added substantially to CAREMAX INC (CMAX), INTRA-CELLULAR THERAPIES INC (ITCI) and MORPHIC HLDG INC (MORF).
PERCEPTIVE ADVISORS LLC Equity Portfolio Value
Last Reported on: 15 May, 2024
PERCEPTIVE ADVISORS LLC Annual Return Estimates Vs S&P 500
Our best estimate is that PERCEPTIVE ADVISORS LLC made a return of 9.95% in the last quarter. In trailing 12 months, it's portfolio return was 46.05%.
New Buys
| Ticker | $ Bought |
|---|---|
| viking therapeutics inc | 81,516,000 |
| cg oncology inc | 57,250,200 |
| praxis precision medicines i | 50,133,400 |
| centessa pharmaceuticals plc | 34,841,400 |
| ocular therapeutix inc | 30,252,700 |
| irhythm technologies inc | 28,443,800 |
| pepgen inc | 20,733,400 |
| engene holdings inc | 16,931,200 |
New stocks bought by PERCEPTIVE ADVISORS LLC
Additions
Additions to existing portfolio by PERCEPTIVE ADVISORS LLC
Reductions
| Ticker | % Reduced |
|---|---|
| amylyx pharmaceuticals inc | -83.95 |
| abbvie inc | -55.25 |
| rapt therapeutics inc | -42.83 |
| macrogenics inc | -38.17 |
| revolution medicines inc | -24.42 |
| cogent biosciences inc | -21.34 |
| bridgebio pharma inc | -19.26 |
| xenon pharmaceuticals inc | -18.95 |
PERCEPTIVE ADVISORS LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| lianbio | -257,256,000 |
| cymabay therapeutics inc | -95,056,300 |
| kronos bio inc | -2,190,930 |
| tango therapeutics inc | -11,007,500 |
| terns pharmaceuticals inc | -6,976,750 |
| rayzebio inc | -46,258,000 |
| olema pharmaceuticals inc | -7,573,830 |
| mirum pharmaceuticals inc | -15,791,500 |
PERCEPTIVE ADVISORS LLC got rid off the above stocks
Sector Distribution
PERCEPTIVE ADVISORS LLC has about 87.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 87.7 |
| Others | 12.1 |
Market Cap. Distribution
PERCEPTIVE ADVISORS LLC has about 7.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 47.9 |
| SMALL-CAP | 28.7 |
| UNALLOCATED | 12.1 |
| LARGE-CAP | 7.2 |
| MICRO-CAP | 2.2 |
| NANO-CAP | 1.5 |
Stocks belong to which Index?
About 0% of the stocks held by PERCEPTIVE ADVISORS LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 100 |
PERCEPTIVE ADVISORS LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC has 105 stocks in it's portfolio. About 40% of the portfolio is in top 10 stocks. FOLD proved to be the most loss making stock for the portfolio. IOVA was the most profitable stock for PERCEPTIVE ADVISORS LLC last quarter.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 0.34 | 106,500 | 19,393,600 | reduced | -55.25 | ||
| ABSI | absci corporation | 0.07 | 700,000 | 3,976,000 | new | |||
| ACAD | acadia pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACLX | arcellx inc | 4.75 | 3,933,560 | 273,579,000 | reduced | -13.45 | ||
| ADMA | adma biologics inc | 0.74 | 6,433,370 | 42,460,200 | unchanged | 0.00 | ||
| AGLE | spyre therapeutics inc | 1.68 | 2,556,680 | 96,974,800 | reduced | -1.92 | ||
| AKRO | akero therapeutics inc | 0.61 | 1,387,470 | 35,047,500 | added | 43.37 | ||
| ALDX | aldeyra therapeutics inc | 0.49 | 8,593,590 | 28,101,000 | unchanged | 0.00 | ||
| AMAM | ambrx biopharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMLX | amylyx pharmaceuticals inc | 0.01 | 300,000 | 852,000 | reduced | -83.95 | ||
| AORT | artivion inc | 0.98 | 2,668,980 | 56,475,600 | added | 186 | ||
| APLT | applied therapeutics inc | 0.94 | 8,005,000 | 54,434,000 | added | 96.19 | ||
| ARQT | arcutis biotherapeutics inc | 0.13 | 750,000 | 7,432,500 | new | |||
| ARVN | arvinas inc | 0.89 | 1,236,600 | 51,047,000 | added | 249 | ||
| ASND | ascendis pharmaa/s | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATHA | athira pharma inc | 0.26 | 5,402,960 | 14,804,100 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 1.58 | 6,485,420 | 91,249,900 | added | 61.97 | ||
| AUTL | autolus therapeutics plc | 0.48 | 4,330,740 | 27,630,200 | added | 136 | ||
| AXGN | axogen inc | 0.22 | 1,553,930 | 12,540,200 | added | 92.23 | ||
| AXSM | axsome therapeutics inc | 1.53 | 1,105,340 | 88,206,200 | added | 6.49 | ||